Marie Thibault
Stock Analyst at BTIG
(3.99)
# 540
Out of 5,067 analysts
97
Total ratings
55.56%
Success rate
9.78%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Reiterates: Buy | $198 | $145.62 | +35.97% | 6 | Nov 24, 2025 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $79.64 | +10.50% | 3 | Nov 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $98.04 | +34.64% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $337.53 | +12.58% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $127.19 | +14.00% | 14 | Nov 20, 2025 | |
| OM Outset Medical | Maintains: Buy | $39 → $17 | $4.33 | +292.61% | 1 | Nov 11, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $1.01 | +296.04% | 2 | Nov 6, 2025 | |
| DCTH Delcath Systems | Reiterates: Buy | $23 | $9.23 | +149.19% | 4 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Buy | $109 → $85 | $62.21 | +36.63% | 8 | Oct 31, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $195 → $215 | $183.21 | +17.35% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.10 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $14.64 | +70.77% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.84 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $37.74 | +37.78% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $69.14 | -5.99% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.28 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.83 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.27 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.48 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $279.61 | -97.85% | 1 | Apr 9, 2020 |
Masimo
Nov 24, 2025
Reiterates: Buy
Price Target: $198
Current: $145.62
Upside: +35.97%
Haemonetics
Nov 21, 2025
Reiterates: Buy
Price Target: $88
Current: $79.64
Upside: +10.50%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $98.04
Upside: +34.64%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $337.53
Upside: +12.58%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $127.19
Upside: +14.00%
Outset Medical
Nov 11, 2025
Maintains: Buy
Price Target: $39 → $17
Current: $4.33
Upside: +292.61%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.01
Upside: +296.04%
Delcath Systems
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $9.23
Upside: +149.19%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $62.21
Upside: +36.63%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $183.21
Upside: +17.35%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.10
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $14.64
Upside: +70.77%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.84
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $37.74
Upside: +37.78%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $69.14
Upside: -5.99%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.28
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.83
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.48
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $279.61
Upside: -97.85%